603858.SS Overview

Company Profile

Shandong Buchang Pharmaceuticals Co., Ltd. engages in the research and development, production, and sale of traditional Chinese medicines in China and internationally. It offers medicines to treat cardiac and cerebral vascular, urinary and digestive, respiratory, gynecological, and other diseases, as well as diabetes. The company was founded in 1993 and is based in Heze, China.

Related stocks

002399.SZ

002399.SZ • China

9.89 CNY

2.17B USD 1Y -16.7%

600267.SS

600267.SS • China

ZHEJIANG HISUN PHARMACEUTICAL C

11.94 CNY

2.11B USD 1Y +13.5%

600867.SS

600867.SS • China

TONGHUA DONGBAO MEDICINES CO LT

7.88 CNY

2.31B USD 1Y -7%

603456.SS

603456.SS • China

ZHEJIANG JIUZHOU PHARMACEUTICAL

16.31 CNY

2.14B USD 1Y -20.9%

605507.SS

605507.SS • China

GUOBANG PHARMA LTD

17.31 CNY

2.03B USD 1Y +7.4%

600216.SS

600216.SS • China

ZHEJIANG MEDICINE

12.59 CNY

1.81B USD 1Y -12.9%

1513.HK

1513.HK • China

22.16 HKD

2.51B USD 1Y -35.7%

600211.SS

600211.SS • China

TIBET RHODIOLA PHARMACEUTICAL H

36.78 CNY

1.77B USD 1Y -22.9%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile

5 Metrics

Country

Region

Sector

Industry

Drug Manufacturers - Specialty & Generic

Website

https://www.buchang.com

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High

5Y Volatility

30.9% p.a.

Max Drawdown (5Y)

-47.9%

Sharpe Ratio (5Y)

-0.24

Beta Factor

0.29

Size Class

Large Cap

Notes & Warnings

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Exemplary balance sheet strength: Very solid ratio of equity to debt.

🔴 High valuation risk: Avg P/E of 64.4 (Elevated multiple compression risk)

Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (30.9% p.a.).

Historical Stress Test: Maximum peak-to-trough drawdown of -83.4% in the extended horizon.